Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Laboratory Glassware Market
The laboratory glassware market size was valued at USD 3.86 billion in 2024 and is anticipated to reach USD 5.54 billion by 2032, at a CAGR of 4.65% during the forecast period (2024-2032).
-
Label Free Array Systems Market
The Label Free Array Systems Market was valued at USD 1.57 billion in 2024 and is projected to reach USD 2.77 billion by 2032, growing at a CAGR of 7.35% during the forecast period.
-
Irritable Bowel Syndrome Treatment Market
The irritable bowel syndrome treatment market size was valued at USD 3.79 billion in 2024 and is anticipated to reach USD 7.33 billion by 2032, at a CAGR of 8.6 % during the forecast period (2024-2032).
-
Intraosseous Infusion Devices Market
The intraosseous infusion devices market size was valued at USD 967.36 million in 2024 and is anticipated to reach USD 1,540.82 million by 2032, at a CAGR of 6 % during the forecast period (2024-2032).
-
UK Cell and Gene Therapy CDMO Market
The UK Cell and Gene Therapy CDMO Market size was valued at USD 26.16 million in 2018 to USD 80.13 million in 2024 and is anticipated to reach USD 287.57 million by 2032, at a CAGR of 16.14% during the forecast period.
-
U.S. Cell and Gene Therapy CDMO Market
The U.S. Cell and Gene Therapy CDMO Market size was valued at USD 759.18 million in 2018 to USD 2,407.80 million in 2024 and is anticipated to reach USD 9,531.51 million by 2032, at a CAGR of 17.50% during the forecast period.
-
North America Cell and Gene Therapy CDMO Market
The North America Cell and Gene Therapy CDMO Market size was valued at USD 896.32 million in 2018 to USD 2,813.27 million in 2024 and is anticipated to reach USD 11,167.45 million by 2032, at a CAGR of 17.54% during the forecast period.
-
Germany Cell and Gene Therapy CDMO Market
The Germany Cell and Gene Therapy CDMO Market size was valued at USD 58.48 million in 2018 to USD 181.63 million in 2024 and is anticipated to reach USD 675.72 million by 2032, at a CAGR of 16.64% during the forecast period.
-
France Cell and Gene Therapy CDMO Market
The France Cell and Gene Therapy CDMO Market size was valued at USD 63.94 million in 2018 to USD 196.78 million in 2024 and is anticipated to reach USD 714.67 million by 2032, at a CAGR of 16.31% during the forecast period.
-
Europe Cell And Gene Therapy CDMO Market
The Europe Cell and Gene Therapy CDMO Market size was valued at USD 371.65 million in 2018, reaching USD 1,112.23 million in 2024, and is anticipated to attain USD 3,991.18 million by 2032, registering a CAGR of 16.05% during the forecast period.
